Journal of Medicinal Chemistry · 1996 · 227 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionLigand BindingMechanisms Of Drug ActionPotency OptimizationStructure-activity Relationship AnalysisTyrosine Kinase InhibitorsEgfr InhibitionPdgfr InhibitorsPlatelet-derived Growth Factor InhibitionPlatelet-derived Growth Factor ReceptorsQuinoxaline ChemistrySelective Tyrosine Kinase InhibitorsSmall Molecule Tyrosine Kinase InhibitorsTyrosine Kinase Inhibition
A series of 3-indoleacrylonitrile tyrphostins, 2-chloro-3-phenylquinolines, and 3-arylquinoxalines were prepared and tested for inhibition of platelet-derived growth factor receptor tyrosine kinase (PDGF-RTK) activity. The potency of the inhibitors was found to be quinoxalines > quinolines > indoles. Lipophilic groups (methyl, methoxy) in the 6 and 7 positions and phenyl at the 3 position of quinoxalines and quinolines were essential for potency, in contrast to the hydrophilic catechol group in tyrphostins active against EGFR kinase inhibition at different sites. The inhibitors showed selectivity for PDGF and were not active against EGF receptor and HER-2/c-ErbB-2 receptor.
15
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.
Per Levéen, Milos Pekny, Samuel Gebré‐Medhin et al. · Genes & Development · 1994 · 1.1K citations · Full text